Excedrin Migraine - NDC Database

13 records found
Page:1
0067-2000 Sep 27, 2006
Excedrin Migraine (Apap 250 mg / Asa 250 mg / Caffeine 65 mg) Oral Tablet by Novartis Consumer Health, Inc.
0067-2021 Sep 13, 2011
Excedrin Migraine (Apap 250 mg / Asa 250 mg / Caffeine 65 mg) Oral Tablet by Novartis Consumer Health, Inc
0067-2030 Sep 27, 2006
Excedrin Migraine (Apap 250 mg / Asa 250 mg / Caffeine 65 mg) Oral Tablet by Novartis Consumer Health, Inc.
0067-2035 Sep 13, 2011
Excedrin Migraine (Apap 250 mg / Asa 250 mg / Caffeine 65 mg) Oral Tablet by Novartis Consumer Health, Inc
0067-2037 Feb 15, 2010
Excedrin Migraine (Apap 250 mg / Asa 250 mg / Caffeine 65 mg) Oral Tablet by Novartis Consumer Health, Inc.
0067-2039 Feb 15, 2010
Excedrin Migraine (Apap 250 mg / Asa 250 mg / Caffeine 65 mg) Oral Tablet by Novartis Consumer Health, Inc.
0067-2045 Oct 31, 2005
Excedrin Tension Headache (Apap 500 mg / Caffeine 65 mg) Oral Tablet by Novartis Consumer Health, Inc.
0067-2053 Mar 01, 2010
Excedrin PM (Apap 500 mg / Diphenhydramine Citrate 38 mg) Oral Tablet by Novartis Consumer Health, Inc.
0067-2055 Jul 01, 2009
Excedrin PM (Apap 500 mg / Diphenhydramine Citrate 38 mg) Oral Tablet by Novartis Consumer Health, Inc.
0067-6238 Feb 15, 2010
Excedrin Back & Body (Apap 250 mg / Asa 250 mg) Oral Tablet by Novartis Consumer Health, Inc.
0067-6341 Dec 10, 2009
Excedrin (Acetaminophen 250 mg / Aspirin 250 mg / Caffeine 65 mg) by Novartis Consumer Health, Inc.
0067-8103 Oct 22, 2012
Excedrin Migraine (Apap 250 mg / Asa 250 mg / Caffeine 65 mg) Oral Tablet by Novartis Consumer Health, Inc.
0067-8104 Jan 16, 2013
Excedrin Migraine (Apap 250 mg / Asa 250 mg / Caffeine 65 mg) Oral Tablet by Novartis Consumer Health, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.